MEHTA NOZER M has a total of 17 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1988. It filed its patents most often in United States and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are JACKSON SIMON MARK, WITHYOU BIOTECHNOLOGY CO LTD and CEL SCI CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 16 | |
#2 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Fermentation | |
#6 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Mehta Nozer M | 17 |
#2 | Stern William | 11 |
#3 | Gilligan James P | 9 |
#4 | Ray Martha V L | 4 |
#5 | Meenan Christopher P | 4 |
#6 | Sturmer Amy | 4 |
#7 | Consalvo Angelo P | 4 |
#8 | Sturmer Amy M | 3 |
#9 | Karsdal Morten Asser | 3 |
#10 | Henriksen Kim | 3 |
Publication | Filing date | Title |
---|---|---|
US2015196617A1 | Peptide analogs for treating diseases and disorders | |
US2005282756A1 | Oral delivery of peptide pharmaceutical compositions | |
US2005221442A1 | Bacterial host cell for the direct expression of peptides | |
US2004197323A1 | Oral delivery of peptides |